- Supported exchanges /
- KQ /
- 042520.KQ
HansBiomed Corporation (042520 KQ) stock market data APIs
HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. The company provides ExFuse, a demineralized bone matrix with cancellous bone gel/putty; BellaFuse, a demineralized bone matrix; Genesis, a cancellous sponge block/filler; Pedi-Stick, a demineralized cortical bone stick; SureChip, a cancellous bone chip; OsteoGrow, a demineralized bone matrix inserter; BellaCell HD, an allograft dermal product that transplanted in a patient whose skin has been lost due to breast cancer; and SureDerm, an acellular dermal matrix. It also offers BELLAGEL, a breast prosthesis, internal, and gel-filled solution; MINT Lift, a PDO thread; EZ-Tcon solution; Lion HT/HN, a hair transplanter body/needle; and Scar Clinic, a scar management solution. The company was formerly known as Hans Medical Corp. and changed its name to HansBiomed Corporation in June 2000. The company was founded in 1990 and is headquartered in Seoul, South Korea.
HansBiomed Corporation Financial Data Overview
| 7850 | |
| 7780 | |
| - | |
| 8090 | |
| 7780 | |
| 6500-16600 | |
| 101 948 M | |
| 12 987 K | |
| 80 639 M | |
| 7.2141 | |
| 0.694 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
HansBiomed Corporation Fundamental Data is available in our Financial Data APIs
- Net Revenue 80 639 M
- EBITDA 2 997 M
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get HansBiomed Corporation Earnings via APIs
- Latest Release 2024-08-14
- EPS/Forecast NaN
Get HansBiomed Corporation End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
